Ignite Creation Date:
2024-05-05 @ 6:32 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00506545
Status:
COMPLETED
Last Update Posted:
2013-11-27
First Post:
2007-07-23
Brief Title:
Study of the Efficacy and Safety of SCH 619734 in Subjects With Chronic Cough From an Unknown Cause Study P04888
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
Study of the Efficacy and Safety of SCH 619734 in Subjects With Chronic Idiopathic Cough
Status:
COMPLETED
Status Verified Date:
2013-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized double-blind placebo-controlled crossover single center study of SCH 619734 in subjects with chronic cough from an unknown cause Subjects will be randomized to receive SCH 619734 or placebo for 7 days with 7 days follow-up After a 6 week washout period subjects will be crossed over to the other treatment The primary objective is to evaluate the effectiveness of SCH 619734 in reducing cough reflex sensitivity as determined by a challenge with capsaicin an agent that induces cough
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| SCH 619734 | None | None | None |